{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T05:34:22Z","timestamp":1700544862826},"reference-count":20,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Canadian Regulatory Strategy for Biotechnology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.vaccine.2011.09.017","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T11:25:15Z","timestamp":1316517915000},"page":"8490-8495","source":"Crossref","is-referenced-by-count":2,"title":["Rapid and accurate determination of the potency of varicella vaccine by quantitative polymerase chain reaction"],"prefix":"10.1016","volume":"29","author":[{"given":"Marsha S.","family":"Russell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Larocque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Farnsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runtao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.09.017_bib0005","first-page":"323","article-title":"Varicella-zoster virus vaccine: molecular genetics","volume":"342","author":"Schmid","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0010","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.09.017_bib0015","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2014United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"issue":"RR-4","key":"10.1016\/j.vaccine.2011.09.017_bib0020","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0025","doi-asserted-by":"crossref","unstructured":"Public Health Agency of Canada. National Advisory Committee on Immunization: Varicella Vaccination Two-Dose Recommendations. Canada Communicable Disease Report, 2010;36:1\u201326. http:\/\/www.phac-aspc.gc.ca\/im\/is-cv\/.","DOI":"10.14745\/ccdr.v36i00a08"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0030","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.80.2.710-722.2006","article-title":"Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion","volume":"80","author":"Ryckman","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0035","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/AEM.02006-08","article-title":"Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry","volume":"75","author":"Gates","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0166-0934(02)00118-0","article-title":"Detection and quantitation of group A rotaviruses by competitive and real-time reverse transcription-polymerase chain reaction","volume":"105","author":"Schwarz","year":"2002","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jmv.20053","article-title":"Quantitation of group A rotavirus by real-time reverse-transcription-polymerase chain reaction: correlation with clinical severity in children in South India","volume":"73","author":"Kang","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jviromet.2004.01.009","article-title":"Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR","volume":"117","author":"Schalk","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biologicals.2005.01.001","article-title":"Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay","volume":"33","author":"Schalk","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jviromet.2005.08.013","article-title":"Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (RotaTeq)","volume":"131","author":"Ranheim","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0065","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/B:BILE.0000025883.04938.4e","article-title":"Development of a varicella virus vaccine stabilizer containing no animal-derived component","volume":"26","author":"Chun","year":"2004","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1045-1056(05)80042-9","article-title":"A collaborative study to assess the proficiency of laboratory estimates of potency of live measles vaccines","volume":"20","author":"Forsey","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/biol.1993.1081","article-title":"A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccines","volume":"21","author":"Forsey","year":"1993","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0080","doi-asserted-by":"crossref","first-page":"174615","DOI":"10.1155\/2011\/174615","article-title":"Bioactivity determination of native and variant forms of therapeutic interferons","volume":"2011","author":"Larocque","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.09.017_bib0085","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/AAC.00342-06","article-title":"Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies","volume":"50","author":"Wang","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132 (December)","key":"10.1016\/j.vaccine.2011.09.017_bib0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jviromet.2008.07.026","article-title":"Centrifugal enhancement of Kaposi's sarcoma-associated virus infection of human endothelial cells in vitro","volume":"154","author":"Yoo","year":"2008","journal-title":"J Virol Methods"},{"issue":"12 (December)","key":"10.1016\/j.vaccine.2011.09.017_bib0095","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/JCM.27.12.2884-2886.1989","article-title":"Continuous high-speed rolling versus centrifugation for detection of herpes simplex virus","volume":"27","author":"Hughes","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.09.017_bib0100","series-title":"Manual of laboratory methods for potency testing of vaccines used in the WHO expanded programme on immunisation","first-page":"191","article-title":"General introduction","author":"WHO","year":"1997"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101423X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101423X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T09:24:28Z","timestamp":1592990668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1101423X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":20,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0264410X1101423X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}